title: Sudden acute leukemia transformation in a MDS patient with del(5q) in complete cytogenetic remission after lenalidomide.
authors.forename: Massimo
authors.initials: M
authors.lastname: Breccia
authors.forename: Laura
authors.initials: L
authors.lastname: Cannella
authors.forename: Roberto
authors.initials: R
authors.lastname: Latagliata
authors.forename: Mauro
authors.initials: M
authors.lastname: Nanni
authors.forename: Michelina
authors.initials: M
authors.lastname: Santopietro
authors.forename: Giuseppina
authors.initials: G
authors.lastname: Loglisci
authors.forename: Antonietta
authors.initials: A
authors.lastname: Ferretti
authors.forename: Rita
authors.initials: R
authors.lastname: Barzotti
authors.forename: Esther N
authors.initials: EN
authors.lastname: Oliva
authors.forename: Giuliana
authors.initials: G
authors.lastname: Alimena
mesh_terms: D000208:Acute Disease; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D002872:Chromosome Deletion; D002895:Chromosomes, Human, Pair 5 / Q000235:genetics; D006801:Humans; D000077269:Lenalidomide; D007951:Leukemia, Myeloid / Q000175:diagnosis* / Q000235:genetics; D008297:Male; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000235:genetics; D032681:Spectral Karyotyping; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D013792:Thalidomide; D000077269:Lenalidomide